Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer

Published:2022-06-29 Issue:13 Volume:82 Page:1264-1272
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Bray Alexander W.¹^ORCID,Duan Rong²³,Malalur Pannaga⁴,Drusbosky Leylah M.⁵,Gourdin Theodore S.¹³,Hill Elizabeth G.²³,Lilly Michael B.¹³

Affiliation:

1. Department of Medicine Medical University of South Carolina Charleston South Carolina USA

2. Department of Public Health Sciences Medical University of South Carolina Charleston South Carolina USA

3. Hollings Cancer Center Medical University of South Carolina Charleston South Carolina USA

4. The Ohio State University Wexner Medical Center Columbus Ohio USA

5. Guardant Health, Inc Redwood City California USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24400

Reference37 articles.

1. Epidemiology of Prostate Cancer

2. The Molecular Evolution of Castration-resistant Prostate Cancer

3. Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

4. Aggressive Variants of Castration-Resistant Prostate Cancer

5. Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers;Frontiers in Oncology;2024-09-10

2. FHOD3 shows clinical significance in progression of ovarian cancer through regulation of caspase-3 signaling pathway;Gene;2024-09

3. A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration–Resistant Prostate Cancer;Clinical Cancer Research;2024-04-29

4. Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer;Frontiers in Oncology;2024-02-21

5. Experience and Lessons Learned in the Treatment of Transforming Small Cell Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review;Case Reports in Oncology;2024-02-14